Albendazole treatment for Giardia intestinalis infections in school children

Southeast Asian J Trop Med Public Health. 1999 Mar;30(1):78-83.

Abstract

A randomized controlled trial, 113 school children with Giardia intestinalis infection were treated with albendazole or tinidazole. Albendazole 400 mg once a day x 3 days and tinidazole 50 mg/kg single dose were given orally to 62 and 51 children, respectively. Parasitological cure was documented when there were > or = 2 times negative stool examination for G. intestinalis at 1-2 weeks after therapy. Thirty-one of 62 (50%) children treated with albendazole and 49 of 51 (96.1%) children treated with tinidazole had parasitological cure (p < 0.001). No major side effects were observed except one case in tinidazole group had severe headache for 30 hours. Albendazole appears to be safe and produced a moderate cure rate for G. intestinalis infection when a 3 day anthelmintic regimen is given.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Abdominal Pain / chemically induced
  • Administration, Oral
  • Adolescent
  • Age Distribution
  • Albendazole / therapeutic use*
  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Child Nutrition Disorders / complications
  • Child, Preschool
  • Feces / parasitology
  • Female
  • Giardiasis / complications
  • Giardiasis / drug therapy*
  • Giardiasis / epidemiology
  • Giardiasis / parasitology
  • Headache / chemically induced
  • Humans
  • Male
  • Prevalence
  • Thailand / epidemiology
  • Tinidazole / therapeutic use*
  • Treatment Outcome

Substances

  • Antiprotozoal Agents
  • Tinidazole
  • Albendazole